Showing results (361-370 of 468) with videos related to
Sort By:
Pageof 47
Circulation|April 1, 2009
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding ScoreSumeet Subherwal, Richard G Bach, Anita Y Chen, et al.The American Journal of Cardiology|May 12, 2007
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Anita Y Chen, et al.Journal of Thrombosis and Thrombolysis|August 3, 2012
Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary interventionYiding Li, Bee-Choo Tai, Winnie Sia, et al.Nature Chemical Biology|August 21, 2025
Site-selective protein editing by backbone extension acyl rearrangementsLeah T Roe, Isabel M Piper, Carly K Schissel, et al.JACC. Cardiovascular Interventions|September 22, 2018
Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION RegistryJay S Shavadia, Matthew T Roe, Anita Y Chen, et al.Circulation. Cardiovascular Interventions|August 7, 2014
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registryAkshay Bagai, Yongfei Wang, Tracy Y Wang, et al.American Heart Journal|September 21, 2015
Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trialPeter Clemmensen, Matthew T Roe, Judith S Hochman, et al.American Heart Journal|July 1, 2008
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitalsMatthew T Roe, Anita Y Chen, Elizabeth R Delong, et al.American Heart Journal|July 6, 2010
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)Sergio Leonardi, Sunil V Rao, Robert A Harrington, et al.Journal of the American Heart Association|November 6, 2016
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary SyndromesJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.Pageof 47